While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...

GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...

Biophytis has expanded its existing partnership with LynxKite Technologies to accelerate AI-driven longevity drug discovery.

Novartis has received the US FDA approval for Cosentyx to treat paediatric patients aged 12 years and above with moderate to severe HS.

Bavarian Nordic has signed a manufacturing agreement with SII, expanding its strategic partnership through a contract for its ...

PRISM BioLab has collaborated with Receptor.AI to integrate AI and physics-guided technologies in the discovery of orally ...

Curatis has signed an exclusive licensing and development agreement with Neupharma for corticorelin to treat peritumoral ...

In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation ...

J&J has announced the US FDA approval for the combination of Tecvayli and Darzalex Faspro for adults with RRMM.

In the warning letter, the FDA alleged that Novo inadequately responded to observations made after an inspection in 2025.

Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to CAR designs tailored for myeloid ...

The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term ...